BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

802 related articles for article (PubMed ID: 9672588)

  • 41. Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate.
    Psychoyos A; Creatsas G; Hassan E; Georgoulias V; Gravanis A
    Hum Reprod; 1993 Jun; 8(6):866-9. PubMed ID: 7688380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Herpes simplex virus type 2 in Brazil: seroepidemiologic survey.
    Da Rosa-Santos OL; Gonçalves Da Silva A; Pereira AC
    Int J Dermatol; 1996 Nov; 35(11):794-6. PubMed ID: 8915732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral bioavailability and in vivo efficacy of the helicase-primase inhibitor BILS 45 BS against acyclovir-resistant herpes simplex virus type 1.
    Duan J; Liuzzi M; Paris W; Liard F; Browne A; Dansereau N; Simoneau B; Faucher AM; Cordingley MG
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1798-804. PubMed ID: 12760851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
    Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
    Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.
    Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T
    J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
    Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
    J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients.
    van Velzen M; Missotten T; van Loenen FB; Meesters RJ; Luider TM; Baarsma GS; Osterhaus AD; Verjans GM
    J Clin Virol; 2013 Jul; 57(3):215-21. PubMed ID: 23582986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.
    Ono N; Iwayama S; Suzuki K; Sekiyama T; Nakazawa H; Tsuji T; Okunishi M; Daikoku T; Nishiyama Y
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2095-102. PubMed ID: 9687413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
    Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
    Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Anti alpha-herpesvirus drugs].
    Koshizuka T; Suzutani T
    Nihon Rinsho; 2012 Apr; 70(4):558-63. PubMed ID: 22568134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.
    Eide K; Moerdyk-Schauwecker M; Stein DA; Bildfell R; Koelle DM; Jin L
    Antivir Ther; 2010; 15(8):1141-9. PubMed ID: 21149921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acyclovir diphosphate dimyristoylglycerol: a phospholipid prodrug with activity against acyclovir-resistant herpes simplex virus.
    Hostetler KY; Parker S; Sridhar CN; Martin MJ; Li JL; Stuhmiller LM; van Wijk GM; van den Bosch H; Gardner MF; Aldern KA
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11835-9. PubMed ID: 8265634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening of herpes simplex virus type 1 isolates for acyclovir resistance using DiviTum® assay.
    Sauerbrei A; Vödisch S; Bohn K; Schacke M; Gronowitz S
    J Virol Methods; 2013 Mar; 188(1-2):70-2. PubMed ID: 23246510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
    Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
    J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic and genotypic acyclovir resistance surveillance of genital herpes simplex virus 2 in South Africa.
    Muller EE; Maseko DV; Kularatne RS
    Antiviral Res; 2022 Apr; 200():105277. PubMed ID: 35271913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination of ganciclovir and trifluridine prevents drug-resistance emergence in HSV-1.
    Schalkwijk HH; Shewakramani NR; Das K; Andrei G; Snoeck R
    Antimicrob Agents Chemother; 2024 May; 68(5):e0011024. PubMed ID: 38619252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice.
    Donalisio M; Quaranta P; Chiuppesi F; Pistello M; Cagno V; Cavalli R; Volante M; Bugatti A; Rusnati M; Ranucci E; Ferruti P; Lembo D
    Biomaterials; 2016 Apr; 85():40-53. PubMed ID: 26854390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of DNA polymerase-associated acyclovir-resistant herpes simplex virus type 1: mutations, sensitivity to antiviral compounds, neurovirulence, and in-vivo sensitivity to treatment.
    Wang LX; Takayama-Ito M; Kinoshita-Yamaguchi H; Kakiuchi S; Suzutani T; Nakamichi K; Lim CK; Kurane I; Saijo M
    Jpn J Infect Dis; 2013; 66(5):404-10. PubMed ID: 24047739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity.
    Burrel S; Bonnafous P; Hubacek P; Agut H; Boutolleau D
    Antiviral Res; 2012 Dec; 96(3):386-90. PubMed ID: 23041200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A screening dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus isolates to acyclovir.
    Danve C; Morfin F; Thouvenot D; Aymard M
    J Virol Methods; 2002 Sep; 105(2):207-17. PubMed ID: 12270654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.